These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 33327542)
1. Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond. Zhang X; Powell K; Li L Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327542 [TBL] [Abstract][Full Text] [Related]
2. Advances in understanding the role and mechanisms of tumor stem cells in HER2-positive breast cancer treatment resistance (Review). Xu L; Han F; Zhu L; Ding W; Zhang K; Kan C; Hou N; Li Q; Sun X Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866766 [TBL] [Abstract][Full Text] [Related]
3. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy? Shima H; Yamada A; Ishikawa T; Endo I Gland Surg; 2017 Feb; 6(1):82-88. PubMed ID: 28210556 [TBL] [Abstract][Full Text] [Related]
4. The Breast Cancer Stem Cells Traits and Drug Resistance. Zheng Q; Zhang M; Zhou F; Zhang L; Meng X Front Pharmacol; 2020; 11():599965. PubMed ID: 33584277 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers to Target Heterogeneous Breast Cancer Stem Cells. Hwang-Verslues WW; Lee WH; Lee EY J Mol Biomark Diagn; 2012; Suppl 8():6. PubMed ID: 24977105 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells. Fan X; Chen W; Fu Z; Zeng L; Yin Y; Yuan H Oncol Lett; 2017 Nov; 14(5):5069-5076. PubMed ID: 29142594 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer stem cells as novel biomarkers. Ray SK; Mukherjee S Clin Chim Acta; 2024 Apr; 557():117855. PubMed ID: 38453050 [TBL] [Abstract][Full Text] [Related]
8. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis. Nogueras Pérez R; Heredia-Nicolás N; de Lara-Peña L; López de Andrés J; Marchal JA; Jiménez G; Griñán-Lisón C Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958993 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications. Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295 [TBL] [Abstract][Full Text] [Related]
10. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium. Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer stem cells. Velasco-Velázquez MA; Homsi N; De La Fuente M; Pestell RG Int J Biochem Cell Biol; 2012 Apr; 44(4):573-7. PubMed ID: 22249027 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer stem cells: The role of sex steroid receptors. Giovannelli P; Di Donato M; Galasso G; Di Zazzo E; Medici N; Bilancio A; Migliaccio A; Castoria G World J Stem Cells; 2019 Sep; 11(9):594-603. PubMed ID: 31616537 [TBL] [Abstract][Full Text] [Related]
13. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome. Sorrentino C; Ciummo SL; D'Antonio L; Fieni C; Lanuti P; Turdo A; Todaro M; Di Carlo E J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663639 [TBL] [Abstract][Full Text] [Related]
15. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity. Zhang R; Tu J; Liu S Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107 [TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance. Saha T; Lukong KE Front Oncol; 2022; 12():856974. PubMed ID: 35392236 [TBL] [Abstract][Full Text] [Related]
17. Cytokines, breast cancer stem cells (BCSCs) and chemoresistance. Chen W; Qin Y; Liu S Clin Transl Med; 2018 Sep; 7(1):27. PubMed ID: 30175384 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells. Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Expression of Autophagy-Related Marker (LC3B) and Stem Cell Marker (CD44) in Molecular Subtypes of Breast Cancer. El-Deek HEM; El-Naggar MS; Sayed SG Asian Pac J Cancer Prev; 2024 Jan; 25(1):145-152. PubMed ID: 38285778 [TBL] [Abstract][Full Text] [Related]
20. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies. Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]